Progress and future challenges in gene vectors, gene therapy systems and gene expressions
Online Publishing @ NISCAIR
View Archive InfoField | Value | |
Authentication Code |
dc |
|
Title Statement |
Progress and future challenges in gene vectors, gene therapy systems and gene expressions |
|
Added Entry - Uncontrolled Name |
Veeman, Dhinakaran Dhamodharan, Duraisami V, M Varsha Shree1 L, Natrayan B, Stalin Ramaswamy, shanmugam Jule, Leta Tesfaye R, Krishnaraj |
|
Uncontrolled Index Term |
Gene expressions; Gene targeting; Gene therapy; Vectors |
|
Summary, etc. |
Genetic engineering has made sizeable contributions to technical innovation, agriculture, and the development of pharmaceuticals. Various approaches were evolved to control the genetic cloth of cells using both viral and nonviral vector architectures. Gene therapy aims to reverse pathological traits with the aid of the use of viral and nonviral gene shipping mechanisms. Gene transfer motors have made massive strides in becoming more environmentally pleasant, much less risky, and nonimmunogenic, as well as making an allowance for lengthy-time period transgene expression. One of the most tough components of correctly enforcing gene healing treatments in the clinical putting is adjusting gene expression extremely tightly and constantly as and while it's required. This research work will cognizance on using viral vectors for gene concentrated on biological applications with various gene expressions. Due to improvements in viral vector engineering and superior gene regulatory systems to permit and adjust tightly therapeutic gene expression, the technology for using genes to offer a preferred treatment has confirmed to be an effective approach |
|
Publication, Distribution, Etc. |
Indian Journal of Biochemistry and Biophysics (IJBB) 2022-11-04 00:00:00 |
|
Electronic Location and Access |
application/pdf http://op.niscair.res.in/index.php/IJBB/article/view/58757 |
|
Data Source Entry |
Indian Journal of Biochemistry and Biophysics (IJBB); IJBB Vol. 59 (11) [November 2022] |
|
Language Note |
en |
|